Marks Fifth Year Finishing in Top Spot for Infection Control and Monitoring Category

CareFusion (NYSE:CFN), a leading global medical technology company, today announced that MedMined® Surveillance Advisor has once again finished first in a KLAS report for Infection Control and Monitoring.

This award marks the fifth year that MedMined Surveillance Advisor has been recognized as the leader for Infection Control and Monitoring by KLAS, an organization that independently monitors health care information technology performance through the active participation of thousands of health care organizations.

"We are honored that hospitals and infection control professionals have once again ranked MedMined Surveillance Advisor as the best technology for Infection Control and Monitoring," said Bert Williams, vice president and general manager of MedMined Services for CareFusion. "Our proprietary technology and methodology not only help clinicians identify areas for improvement, but the infection data is tied to data from the hospital's financial systems to show the true costs of every infection across the system."

MedMined Surveillance Advisor provides automated infection surveillance proven to help hospitals identify and reduce health care associated infections (HAIs)-ultimately facilitating hospitals' efforts to save lives and reduce costs. The proprietary tool uses a proxy marker to identify potential HAIs, while algorithms automatically detect clinically meaningful patterns in complex data sets, similar to the data mining technology used by credit card companies to detect fraud. By placing the right information in the right hands at the right time, the infection prevention team is empowered to efficiently focus resources on emerging trends in HAIs and multiple-drug resistant organisms. This refined approach to electronic surveillance allows for more time to be spent on clinical intervention and education.

MedMined Surveillance Advisor has been studied and published in numerous peer-reviewed publications, as well as financially peer-reviewed receiving the Healthcare Financial Management Association Peer Review designation.

About CareFusion Corporation
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps and IV sets, MaxPlus® and MaxZero™ IV connectors and sets, Pyxis® automated dispensing and patient identification systems, AVEA®, LTV® series and AirLife® ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 16,000 people across its global operations. More information may be found at http://www.carefusion.com/.

About KLAS
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience.www.twitter.com/KLASresearch.

For further information: Media: Troy Kirkpatrick, (858) 617-2361, troy.kirkpatrick@carefusion.com or Investors: Jim Mazzola, (858) 617-1203, jim.mazzola@carefusion.com

distributed by